Related references
Note: Only part of the references are listed.Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment
Wenxi Zhou et al.
BIOMATERIALS (2021)
Bone marrow mesenchymal stem cells-derived exosomes for penetrating and targeted chemotherapy of pancreatic cancer
Yu Zhou et al.
ACTA PHARMACEUTICA SINICA B (2020)
Dendritic cells in cancer immunology and immunotherapy
Stefanie K. Wculek et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Anchor peptide captures, targets, and loads exosomes of diverse origins for diagnostics and therapy
Xianjun Gao et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Exosomes from M1-Polarized Macrophages Potentiate the Cancer Vaccine by Creating a Pro-inflammatory Microenvironment in the Lymph Node
Lifang Cheng et al.
MOLECULAR THERAPY (2017)
Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy
Yuchen Fan et al.
NANO LETTERS (2017)
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
Sushrut Kamerkar et al.
NATURE (2017)
Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges
Katharina Maisel et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Have lessons from past failures brought us closer to the success of immunotherapy in metastatic pancreatic cancer?
Laura Rosa Brunet et al.
ONCOIMMUNOLOGY (2016)
Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells
Myung Soo Kim et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
Lymphatic transport of exosomes as a rapid route of information dissemination to the lymph node
Swetha Srinivasan et al.
SCIENTIFIC REPORTS (2016)
Nanovaccine loaded with poly I:C and STAT3 siRNA robustly elicits anti-tumor immune responses through modulating tumor-associated dendritic cells in vivo
Zichao Luo et al.
BIOMATERIALS (2015)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseases
Thanh-Huyen Tran et al.
CLINICAL IMMUNOLOGY (2015)
The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment
Gregory K. Pennock et al.
ONCOLOGIST (2015)
Structural basis for ineffective T-cell responses to MHC anchor residue-improved heteroclitic peptides
Florian Madura et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Dynamic Biodistribution of Extracellular Vesicles in Vivo Using a Multimodal Imaging Reporter
Charles P. Lai et al.
ACS NANO (2014)
Two immune faces of pancreatic adenocarcinoma: possible implication for immunotherapy
Alexandr V. Bazhin et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Dendritic Cell-Derived Exosomes as Immunotherapies in the Fight against Cancer
Jonathan M. Pitt et al.
JOURNAL OF IMMUNOLOGY (2014)
Structure-based programming of lymph-node targeting in molecular vaccines
Haipeng Liu et al.
NATURE (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Sodium and Cardiovascular Disease
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Pancreatic cancer stroma: understanding biology leads to new therapeutic strategies
Agnieszka Anna Rucki et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Inflammatory networks and immune surveillance of pancreatic carcinoma
Robert H. Vonderheide et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
The Epidemiology of Pancreatitis and Pancreatic Cancer
Dhiraj Yadav et al.
GASTROENTEROLOGY (2013)
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans
Daisuke Sugiyama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes
Angela Montecalvo et al.
BLOOD (2012)
T-cell Receptor-optimized Peptide Skewing of the T-cell Repertoire Can Enhance Antigen Targeting
Julia Ekeruche-Makinde et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Cross-presentation by dendritic cells
Olivier P. Joffre et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Early Detection of Tumor Cells by Innate Immune Cells Leads to Treg Recruitment through CCL22 Production by Tumor Cells
Julien Faget et al.
CANCER RESEARCH (2011)
Chemotherapy Delivered After Viral Immunogene Therapy Augments Antitumor Efficacy Via Multiple Immune-mediated Mechanisms
Zvi G. Fridlender et al.
MOLECULAR THERAPY (2010)
Melan-A/MART1 Analog Peptide Triggers Anti-myeloma T-cells Through Crossreactivity With HM1.24
Olaf Christensen et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Taking dendritic cells into medicine
Ralph M. Steinman et al.
NATURE (2007)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88
Seth Rakoff-Nahoum et al.
SCIENCE (2007)
Calreticulin exposure dictates the immunogenicity of cancer cell death
Michel Obeid et al.
NATURE MEDICINE (2007)
Dendritic cells as therapeutic vaccines against cancer
J Banchereau et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
J Wolfers et al.
NATURE MEDICINE (2001)
Share Paper
